Cancer Treatment Results  Survival Rates Cancer Treatments / Therapy Results

Click here to go back to your search results.

Prostate Cancer treatment details. Chemotherapy. University Hospital Hamburg-Eppendorf, Hamburg, Germany

Survival: 18.7 months
Toxicity Grade: 4
Treatments: Chemotherapy
Country: Germany
City/State/Province: Hamburg
Hospital: University Hospital Hamburg-Eppendorf
Journal: Link
Date: 1/2006

Patients: This Phase II study involved 34 men with hormone refractory prostate cancer. The median age was 67 years. Previous therapies included surgery (13 patients), radiation (24), and estramustine chemotherapy (14). Metastatic sites included lymph nodes, liver, and lung.

Treatment: The treatment consisted of one chemotherapeutic agent: sabarubicin.

Toxicity: Grade 3-4 toxicities included neutropenia, leukopenia, anemia, cardiac toxicity, and thrombocytopenia.

Results: The median overall survival was 18.7 months. One patient had a partial response, and seven had stable disease.

Correspondence: W. Fiedler

E-mail to a Friend Email Physician More Information